Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Miltefosine bulk supplier for pharma manufacturers

Miltefosine 10 mg, 50 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 10 mg, 50 mg

Reference Brands: Impavido (USA/EU)

Category: Anti-fungal

Miltefosine is an oral antiprotozoal agent used to treat visceral, cutaneous, and mucosal leishmaniasis. It works by disrupting cell membrane phospholipid metabolism in Leishmania parasites, leading to parasite death. It is also used as part of combination therapy for rare amoebic infections. The treatment is taken orally for several weeks and requires monitoring for gastrointestinal effects and liver or kidney function changes. It should not be used during pregnancy due to teratogenic risks.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Miltefosine — third party manufacturing & bulk supply

Miltefosine 10 mg, 50 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Miltefosine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Miltefosine →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Miltefosine is used for the treatment of leishmaniasis, including visceral, cutaneous, and mucocutaneous forms. It is also sometimes used for certain rare amoebic infections such as Naegleria fowleri.

Miltefosine is a synthetic alkylphosphocholine compound designed to disrupt parasite cell membranes and inhibit their metabolic pathways.

The commonly known trade name is Impavido.

Miltefosine is produced by several manufacturers globally, with Impavido originally developed by Aeterna Zentaris and later marketed by other licensed pharmaceutical companies.

The generic name is miltefosine.

The brand name is Impavido.

Miltefosine is manufactured by various pharmaceutical companies in India and other regions that specialize in anti-parasitic and neglected tropical disease medicines.

Related Products

Tioconazole

Strength:
6.5%, 300 mg, 1%

Form: Vaginal Capsule / Vaginal Cream/ topical cream

Reference Brands: Vagistat-1 (USA), Trosyd (EU/LATAM)

View Details
Terconazole

Strength:
0.4%, 0.8%, 80 mg, 120 mg

Form: Cream / Vaginal suppository

Reference Brands: Terazol (USA)

View Details
Tavaborole

Strength:
5%

Form: Topical Solution

Reference Brands: Kerydin (USA/EU)

View Details
Rezafungin Acetate

Strength:
200 mg

Form: Injection

Reference Brands: Rezzayo (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.